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Interviewing Dr Felipe Fregni: A Pathway to a Research 
Career
Juliana Bonilla-Velez,1 Whitney Stefanny Cordoba-Grueso.2
A talented Brazilian physician investigator, Felipe Fregni, is an 
Associate Professor of Physical Medicine & Rehabilitation and 
Neurology at Harvard Medical School, where he directs the 
Neuromodulation Laboratory at the Department of Physical 
Medicine & Rehabilitation at Spaulding Rehabilitation Hospital 
& Massachusetts General Hospital. He completed his medical 
studies, Neurology residency, and a Doctor of Philosophy (PhD) 
at the University of Sao Paulo and continued on to pursue post-
graduate studies as well as a Master of Public Health (MPH) at 
Harvard Medical School. His philanthropic nature led him to 
design the Collaborative Learning in Clinical Research Program 
and the Principles and Practice of Clinical Research course with 
the Department of Continuing Education at Harvard Medical 
School to educate on basic and advanced training in clinical 
trials for physicians around the world.1 As part of this cour-
se, he has reached to physicians and students of graduate 
and postgraduate studies in the medical field in 30 countries 
to offer a 9-month collaborative distance-learning course on 
clinical research. For this interview, he was invited to share 
his experiences and insight as a physician-scientist from Brazil 
with medical students worldwide.
1. Can you share with us a glimpse of your life history? Can you 
describe how your research career started?
I completed my medical school studies and residency at the 
University of Sao Paulo, Brazil. In the last months of my re-
sidency, I initiated my doctoral studies. The first time that I 
traveled to the United States was in 2000, where I completed 
an initial observership in the Department of Neurology at the 
Beth Israel Deaconess Medical Center (BIDMC) at Harvard Me-
dical School. Here, I met the the Principal Investigator of the 
Laboratory of Brain Non-invasive Stimulation. Then, I went back 
to Brazil to finish my residency and continue my PhD studies. 
By the end of my PhD, I came back to Boston and started my 
post-doctorate fellowship.
When I came initially, I didn’t know if I wanted to stay or not. 
I was open to opportunities. In my opinion, research is very 
important for you as a clinician. I knew that there are many li-
mitations in the treatments we offer to patients and in order to 
understand and to provide better care, you need to understand 
science and research well. And this is where my motivation 
was to come to the USA, a place where there was more focus 
on research integrated in clinical practice.
I then started the Scholars in Clinical Science Program followed 
by my MPH in the Clinical Effectiveness program at Harvard 
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Figure 1. Dr. Felipe Fregni.
The International Journal of Medical Students Int J Med Students   •   2015  |  2014 Nov-2015 Mar  |  Vol  3  |  Issue 168
IJMS
International Journal of 
Medical Students Interview
School of Public Health. At this point, my research was going 
well; I was getting published and I was offered a position initia-
lly as Instructor and then as Assistant Professor of Neurology. 
Then, I was faced with the decision about whether I wanted 
to go back to more clinical work or stay more centered in re-
search, and I chose to stay more dedicated to research and 
teaching. At this point, I was then recruited to Spaulding Reha-
bilitation Hospital where I have my own laboratory to continue 
my projects. And now I do most of my time in research 
2. What were your thoughts and professional goals when you 
were a medical student?
As a medical student, what you are most focused on is figuring 
out in what you want to do your residency, and I was very 
open to specialties. One of my last rotations was neurology 
and I realized I really liked it. At this stage, I was focused on 
what my next step was going to be and that was residency so 
that was my main concern. I had thought about research and I 
knew I liked research. As a medical student, I was very critical 
of what I heard from my professors and if there was evidence 
to support our decisions, I was always questioning. I wouldn’t 
imagine that when I graduated so many years ago that I would 
be here now and doing what I do now. I think you should be 
open to opportunities.
 
3. Was there a defining moment when things changed?
I think it was more a process. I had ideas in my head and 
there were issues in clinical practice that I wasn’t happy and I 
didn’t know how to resolve these issues- issues that kept me 
thinking. Then I thought that if I went through a research career 
and if I understood more and by doing that I would become 
even more passionate about Neurology. So I think it was a pro-
cess, it took me since finishing medical school about 5-6 years 
to see that this was really what I wanted to do. I saw that this 
made sense in terms of what I believed in. I was never satisfied 
with current knowledge in medicine and the simplistic model 
for diseases and I wanted to do something different, to propose 
a change, and this would only be possible through research 
and producing new knowledge. 
In my first year of medical school, before there was Internet, I 
came across a book in our medical school’s library written by 
an editor of the New Scientist Journal, and I can never remem-
ber the actual name nor have I been able to find it, but it was 
called something like “The Magic Bullet” saying that there are 
so many limitations with drugs and that we don’t fully unders-
tand what they’re really about and then discusses the limita-
tions of our knowledge. This helped me appreciate Medicine 
with different eyes. I think everything happens for a reason.
4.What was the process for you to arrive to your current line 
of research?
It was a couple of things. When I was doing my observership 
at BIDMC, I was with a group of students and one of them 
told me he was working in a laboratory that worked on brain 
stimulation and I thought that was very cool so I went to see 
it. For me it made a perfect match. It was a technique that 
could study brain plasticity, how the brain changes according to 
disease and behavioral stimulation and based on that it went 
across different conditions like stroke and Parkinson’s disease, 
which gave me the opportunity to keep working on different 
conditions focused on learning more about how diseases chan-
ge neuroplasticity and how these changes are locked. It was a 
great field for learning more in general as opposed to focusing 
on a very specific question, which was more what I wanted to 
do, something that would transcend, seeing a bigger picture
5. What is the contribution of your area of research to healthca-
re and answering the health problems that we face? What are 
the biggest challenges?
I think the main thing that we are showing is how the brain 
changes with diseases and that is important. Your brain chan-
ges because you have a lot of neurotransmitters released in 
response to disease or to a lesion, for example in stroke, but 
it also changes trying to adapt, trying to compensate for what 
has happened. So we’re showing that, and showing that if you 
try to block or reverse some of these changes you can induce 
therapeutic effects. So this is a great contribution to clinical 
care. We’re showing with quantitative methods that its not only 
disease but what we call maladaptive plasticity that has an 
effect on the brain. And in stroke we’re showing that if you go 
not to the side of the lesion but to the contralateral side you 
can induce an improvement as well. We have also seen that if 
you have a lesion it can cause an excitability of the areas that 
cause chronic pain, and then the brain becomes more sensitive 
to stimulus in pain-related centers. So these are some of the 
contributions we are giving to medicine.
6. In your opinion, what is the future of research in Neurology?
It’s a difficult question. I think research should be more balan-
ced in terms of basic science and clinical so it can have more 
translation. For example, I gave a presentation on the PPCR 
course showing how we spend millions of dollars to develop 
interventions for acute stroke, from ten that showed great re-
sults in animals only one of them showed a significant result 
in humans in a small phase II trial and when it went to phase 
III trial it showed no changes. So, I think it is important to have 
more effort placed on translation. Another area that would help 
develop the field is finding better biomarkers for neurological 
diseases. There are no biomarkers for pain or stroke; there are 
some that can be used but they’re not very reliable for Parkin-
son’s disease and Alzheimer’s disease, and you can see clinical 
outcomes - which is fine- but we don’t have biomarkers as 
you have for other diseases like enzymes in myocardial injury. 
In PMNR the great challenges are in terms of testing because 
most interventions are based on physical, occupational, and 
speech therapy more than pharmacological therapies, and 
these haven’t been tested systematically. By studying them 
better it can help us understand which patients respond better 
to which treatments. So having more large open label studies 
would be interesting as well.
7. What has been the greatest accomplishment in your career?
It’s difficult to say, but for example for me some great accom-
plishments are having my own laboratory and mentoring stu-
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dents, as well as becoming faculty here. But one thing I think is 
a great accomplishment and I am very passionate about is the 
clinical research course because I think it is the only way you 
can have a system changed is though spreading knowledge. I 
think it would be a combination of these things. And also the 
research findings we’ve already discussed.
8. How have you contributed to the advancement of clinical 
research in developing countries?
This for me is very important. I’ve contributed in two ways. The 
mission is to improve clinical practice and to improve the level 
of clinical care because we can not just do all things ourselves 
so we need to try to help in areas where there’s more need. 
There are different ways to help: one of them is the clinical 
research course, which was designed to be an international 
course with colleagues in Brazil and it has now reached many 
countries. Another one has been pursuing collaborations with 
some of the laboratories in developing countries. I know they 
face difficulties doing research at different levels, for exam-
ple getting the equipment, so through our collaboration we’ve 
been able to do great projects together. 
10. What advice would you give medical students who are inte-
rested in getting involved in research?
I think as medical students you need to be a bit lucky and be in 
a good school with good mentors and be more critical. What’s 
most important is that you should choose your mentor and not 
only the mentor that is available to you, and that sometimes is 
hard to do. This is a match that serves both ways. I don’t think 
in medical school the topic is as important – what to research 
in – but I think its more about who you choose to work with 
because then you learn what research is about; you learn the 
methods. 
9. What advice do you have for medical students worldwide?
In the context of evidence-based medicine, I’d say be curious 
and critical of what you learn. Don’t just do research because 
it improves your CV; understanding research can lead you to 
do better clinical medicine and then look for someone who can 
really help you achieve that. And for future clinical investiga-
tors, you need to devote time and dedication to really learn 
well because it will take more than just 6 months of doing 
research. Working hard, you need 3 to 4 years to be able to 
then be independent in research.
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